Dr Reddy's leaves Genpact to handle its financing
Dr Reddy’s will outsource its company-wide finance and accounting to Genpact in a bid to cut fixed costs.
Dr Reddy’s will outsource its company-wide finance and accounting to Genpact in a bid to cut fixed costs.
Biopharma mergers are a “key problem” for manufacturing quality teams as the loss of focus can lead to regulatory actions, a compliance expert said.
Cetero Research will discuss restructuring its Canadian operations next week as it edges closer to an $80m sale to secured lenders.
Chinese CRO ShangPharma wants to end “confusion in the market” by distancing itself fromShanghai Pharmaceuticals Holdings.
The US Pharmacopeial Convention (USP) has introduced new elemental impurity standards to replace what it says were outdated guidelines.
Kemwell is set to complete a new biologics manufacturing facility in Bangalore, India, following its long-term partnership with Boehringer Ingelheim.
The number of microbial contamination deficiencies identified by MHRA GMP inspectors doubled in fiscal 2011.